Veoneer Stock Price, Forecast & Analysis (NYSE:VNE)

Veoneer trades on the New York Stock Exchange (NYSE) under the ticker symbol "VNE."

Veoneer Inc (NYSE:VNE) posted its earnings results on Wednesday, October, 23rd. The company reported ($1.20) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($1.34) by $0.14. The firm earned $462 million during the quarter, compared to analysts' expectations of $475.33 million. Veoneer had a negative net margin of 26.11% and a negative return on equity of 27.00%. The company's quarterly revenue was down 12.2% compared to the same quarter last year. During the same period last year, the company posted ($0.78) EPS. View Veoneer's Earnings History.

Veoneer is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Veoneer.

13 brokerages have issued 1-year price objectives for Veoneer's shares. Their forecasts range from $14.00 to $43.00. On average, they expect Veoneer's share price to reach $26.40 in the next year. This suggests a possible upside of 71.7% from the stock's current price. View Analyst Price Targets for Veoneer.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veoneer in the last year. There are currently 1 sell rating, 8 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Veoneer.

Media coverage about VNE stock has trended very negative on Tuesday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Veoneer earned a news sentiment score of -3.4 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Veoneer.

Veoneer saw a increase in short interest in the month of October. As of October 31st, there was short interest totalling 8,550,000 shares, an increase of 5.7% from the September 30th total of 8,090,000 shares. Based on an average daily trading volume, of 659,500 shares, the short-interest ratio is presently 13.0 days. Approximately 7.7% of the company's shares are short sold. View Veoneer's Current Options Chain.

Some companies that are related to Veoneer include Allison Transmission (ALSN), LCI Industries (LCII), Dana (DAN), Dorman Products (DORM), Adient (ADNT), Meritor (MTOR), Gentherm (THRM), Standard Motor Products (SMP), American Axle & Manufact. (AXL), Delphi Technologies (DLPH), Stoneridge (SRI), Garrett Motion (GTX), Tenneco (TEN), Tower International (TOWR) and IOCHPE MAXION S/S (IOCJY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Veoneer investors own include Canadian Zinc (CZN), Bayer (BAYN), Seeing Machines (SEE), Eyegate Pharmaceuticals (EYEG), Netflix (NFLX), PepsiCo (PEP), Autoliv (ALV), The Coca-Cola (KO), Prudential Financial (PRU) and ESSILOR INTL S/S (ESLOY).

Veoneer's stock is owned by a variety of of retail and institutional investors. Top institutional investors include DNB Asset Management AS (0.75%), California Public Employees Retirement System (0.19%), State of New Jersey Common Pension Fund D (0.13%), Gateway Investment Advisers LLC (0.10%), First Trust Advisors LP (0.08%) and Great West Life Assurance Co. Can (0.04%). Company insiders that own Veoneer stock include Arthur Blanchford, Jan Carlson, Mathias Hermansson and Mikko S Taipale. View Institutional Ownership Trends for Veoneer.

VNE stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS and Gateway Investment Advisers LLC. View Insider Buying and Selling for Veoneer.

VNE stock was bought by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, California Public Employees Retirement System, First Trust Advisors LP, Great West Life Assurance Co. Can and Zurcher Kantonalbank Zurich Cantonalbank. Company insiders that have bought Veoneer stock in the last two years include Arthur Blanchford, Jan Carlson, Mathias Hermansson and Mikko S Taipale. View Insider Buying and Selling for Veoneer.

Shares of VNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VNE stock can currently be purchased for approximately $15.38.

Veoneer has a market capitalization of $1.71 billion and generates $2.23 billion in revenue each year. The company earns $-275,000,000.00 in net income (profit) each year or ($3.17) on an earnings per share basis. Veoneer employs 8,600 workers across the globe.View Additional Information About Veoneer.

The official website for Veoneer is http://www.veoneer.com/.

Veoneer's mailing address is KLARABERGSVIADUKTEN 70 SECTION C6 BOX 13089, STOCKHOLM V7, 10302. The company can be reached via phone at 46-8-527-762-00 or via email at [email protected]